• 1
    Flanders WD. Review: Prostate cancer epidemiology. Prostate 1984;5:621629.
  • 2
    Wynder EL, Fujita Y, Harris R, Hirayama T, Hiyama T. Comparative epidemiology of cancer between the United States and Japan. Cancer 1991;67:746763.
  • 3
    Ohno Y, Kubo N, Kuroishi T. Epidemiologic characteristics of prostate cancer. In: TakayamaS, YamaguchiT, (eds) Progress in Cancer Clinics No. 32. Tokyo : Medical View, 1990:5867 (in Japanese).
  • 4
    Imai H, Kawai K, Miyazawa T. Nihon Tihou Kosyosi, Kanto Thou (History of local mines in Japan, Kanto region). Tokyo : Asakura Publishing, 1973:79217 (in Japanese).
  • 5
    Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. VI, IARC Scientific Publication, No. 120. Lyon : International Agency for Research on Cancer, 1992:868.
  • 6
    Parkin DM, Muir CS, Whelan SL, Gao YT, Ferlay J, Powell J. Cancer Incidence in Five Continents, Vol. VI, IARC Scientific Publication, No. 120. Lyon : International Agency for Research on Cancer, 1992:970971.
  • 7
    Boring CC, Squires TS, Tong T, Montgomery S. Cancer statistics, 1994. CA Cancer J Clin 1994;40(1)726.
  • 8
    Muir CS, Nectoux J, Staszewki J. The epidemiology of prostatic cancer. Acta Oncol 1991;30(2):133140.
  • 9
    Shimizu H, Ross RK, Bemstein L, Yatani R, Henderson BE, Mack TM. Cancers of the prostate and breast among Japanese and white immigrants in Los Angeles County. Br J Cancer 1991;63:963966.
  • 10
    Department of Public Health and Environment, Health Management Division, Gunma Prefectural Government. National Nutrition Survey in 1991, Summary in Gunma Prefecture. Maebashi : Gunma Prefectural Government, 1993:19 (in Japanese).
  • 11
    Muir C, Waterhouse J, Mack T, Powell J, Whelan S. Cancer Incidence in Five Continents, Vol. V, IARC Scientific Publication, No. 88. Lyon : International Agency for Research on Cancer, 1987:896897.
  • 12
    Nemoto R, Harada M. Clinicopathological studies on prostate cancer. Acta Urol Jpn 1982;28(3):269271 (in Japanese).
  • 13
    Krain LS. Epidemiologic variables in prostatic cancer. Geriatrics 1973;28:9398.
  • 14
    Fincham SM, Hill GB, Hanson J, Wijayasinghe C. Epidemiology of prostatic cancer: A case-control study. Prostate 1990;17:189206.
  • 15
    Armenian HK, Lilienfeld AM, Diamond EL, Bross ID. Epidemiologic characteristics of patients with prostatic neoplasms. Am J Epidemiol 1975;102(1):4754.
  • 16
    Kipling MD, Waterhouse JAH. Cadmium and prostatic carcinoma. Lancet 1967;1:730731.
  • 17
    Lemen RA, Lee JS, Wagoner JK, Blejer HP. Cancer mortality among cadmium production workers. Ann NY Acad Sci 1976;271:273279.
  • 18
    Elghany NA, Schumacher MC, Slattery ML, West DW, Lee JS. Occupation, cadmium exposure, and prostate cancer. Epidemiology 1990;1:107115.
  • 19
    Bako G, Smith ESO, Hanson J, Dewar R. The geographical distribution of high cadmium concentrations in the environment and prostate cancer in Alberta. Can J Public Health 1982;73:9294.
  • 20
    Sanchez AG, Antona JF, Urrutia M. Geochemical prospection of cadmium in a high incidence area of prostate cancer, Sierra de Gata, Salamanca, Spain. Sci Total Environ 1992;116:243251.
  • 21
    Watanabe H, Mishina T, Ohe H, Araki H, Nakao M. A clustering of prostatic cancer in an area with many manganese mines. Tohoku J Exp Med 1981;135:441442.
  • 22
    Ross RK, Paganini-Hill A, Henderson BE. The etiology of prostate cancer: What does the epidemiology suggest Prostate 1983;4:333344.
  • 23
    Tromp SW. Statistical study of the possible relationship between mineral constituents in drinking-water and cancer mortality in the Netherlands (Period 1900–1940). Br J Cancer 1954;8:585593.
  • 24
    Marjanen H. Possible causal relationship between the easily soluble amount of manganese on arable soil and susceptibility to cancer in Finland. Ann Agric Fenn 1969;8:326334.
  • 25
    Sauderman FW, Lau TJ, Crally LJ. Inhibitory effect of manganese upon muscle tumorigenesis by nickel subsulfide. Cancer Res 1974;34:9295.
  • 26
    Barch DH, Iannaccone PM. Role of zinc deficiency in carcinogenesis. Adv Exp Med Biol 1986;206:517527.
  • 27
    Newbern PM, Locniskar M. Roles of micronutrients in cancer prevention: Recent evidence from the laboratory. Prog Clin Biol Res 1990;346:119134.
  • 28
    Ashley DBJ. On the incidence of carcinoma of the prostate. J Pathol Bacteriol 1965;90:217224.
  • 29
    Armitage P, Doll R. The age distribution of cancer and a multi-stage theory of carcinogenesis. Br J Cancer 1954;8:112.
  • 30
    Carter HB, Piantadosi S, Isaacs JT. Clinical evidence for and implications of the multistep development of prostate cancer. J Urol 1990;143:742746.
  • 31
    Kolonel LN, Yoshizawa CN, Hankin JH. Diet and prostatic cancer: A case-control study in Hawaii. Am J Epidemiol 1988;127:9991012.
  • 32
    Oishi K, Okada K, Yoshida O, Yamabe H, Ohno Y, Hayes RB, Schroeder FH. A case-control study of prostatic cancer with reference to dietary habits. Prostate 1988;12:179190.
  • 33
    Berg JW. Can nutrition explain the pattern of international epidemiology of hormone-dependent cancers Cancer Res 1975;35:33453350.
  • 34
    Mandel JS, Schuman LM. Sexual factors and prostatic cancer: Results from a case-control study. J Gerontol 1987;42:259264.
  • 35
    Debre B, Geraud M, Flam T, Steg A. Epidemiology of prostatic cancer. J Int Med Res 1990;18:37.